Articles

Biotechnology firm Iveric Bio shot up on a regulatory green light for its key therapeutic, sparking interest in high-risker play ISEE stock. More

Wondering what are the best stocks to buy now that Republicans have taken back the House? These are the most well-positioned companies. More

These three potential M&A deals run the gamut from very possible to very unlikely, despite the benefits of a transaction getting done. More

Ginkgo Bioworks has tumbled this week, but Cathie Wood is among the key buyers of DNA stock, picking up shares yesterday. More

While Satixfy Communications certainly commands strong fundamental potential, SATX stock remains a high-risk proposition. More

Here's why investors may want to be careful with GRND stock following today's incredible momentum-driven rally. More

These are the best growth stocks to buy for 2023 with the business that they represent having potential catalysts. More

Subscriber Sign in